|
⚲
|
| Keyboard |
| EPIQ Capital Group LLC
✚
|
|
|---|---|
| CRD # | 292526 |
| SEC # | 801-112887 |
| CIK # | 0001779453 |
| AUM | |
| Employees | 60 (53% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 415-433-3747 |
| Address | 1 Lombard St 200 San Francisco, CA 94111 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (10/9/2024) [Brochure] |
|---|
ITEM 5: Fees & Compensation
Advisory & Other Fees We Charge
Depending on circumstances, clients or investors pay us different types of fees, including:
Advisory fees
Management fees
Performance‐based incentive fees (i.e., “carry”)
Service fees
Each of these fee types and the circumstances to which they apply are described more fully below.
Advisory Fees
Client advisory fee schedules are negotiated on a client‐by‐client basis and are determined based upon a number
of factors including, but not limited to, the amount and type of work involved, the services offered, the size of the
portfolios and the amount of our resources dedicated to providing the services. Investment advisory fees based on
assets under management are billed on a pro‐rata, annualized basis, quarterly in arrears, based on the average daily
balance of the client portfolio for the quarter. Clients generally pay an annual fee of up to a maximum of 1.5% of
assets under management. In some cases, the advisory fee includes a minimum quarterly amount or fees for
administration of investments that are not advised on by us. In addition, some clients have flat fee structures that
are not based on assets under management.
Generally, client billable investments include only those accounts and investments authorized in a Client Direction
Letter. Clients may request a copy of an Advisory Scope report from their client team, which details the
investments that they have approved on a Client Direction Letter and on which we bill. Advisory fees may be
modified by us upon notice to clients.
Our firm or a client may terminate our agreement at any time by providing a written thirty (30) day notice to the
other party. After notice of termination has been received, our firm will continue to charge its advisory fees to a
client up to and including the actual date of termination.
6 EPIQ Capital Group, LLC | Form ADV Part 2A: Firm Brochure
Investment Management Fees
Investors who do not have an advisory relationship with EPIQ generally pay a management fee of up to 1.5%
annually of the aggregate value of their interest in the Vehicle. Any Vehicle management fee is waived for clients
who maintain an advisory relationship with our firm under which they are paying advisory fees discussed above.
The management fee is documented in each Vehicle’s constituent documents or in a side letter agreement with the
investor paying the management fee. EPIQ has the right to waive the management fee for any client or investor in
its discretion. |
| Account Minimums and Types of Clients — Form ADV Part 2A (10/9/2024) [Brochure] |
|---|
ITEM 7: Types of Clients & Account Requirements
Our firm has the following types of clients:
High Net Worth Individuals (“HNW Individuals”),
Trusts, Estates or Charitable Organizations associated with HNW Individuals,
Retirement Accounts of HNW Individuals, and
Corporations, Limited Liability Companies and/or Other Business Types associated with HNW Individuals.
Our firm generally requires clients to have a minimum of $50 million in investable assets. This requirement may be waived at
our discretion on a client‐by‐client basis based on our understanding of a prospective client’s overall financial position and
potential asset base. |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Reddit Inc | 26.7 | ||
| iShares Comex Gold Trust | 26.3 | ||
| Facebook Inc | 20.3 | ||
| SPDR Gold Trust | 16.8 | ||
| Rubrik Inc | 13.5 | ||
| Applovin Corp | 12.8 | ||
| Apple Inc | 4.5 | ||
| Alibaba Group Holding Ltd | 3.5 | ||
| JDcom Inc | 2.6 | ||
| Datadog Inc | 2.4 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | EPQ LLC DGNR VI PS | [2023-03-31] | 52.0 M | |
| Filed 2021-08-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Antios B PS | [2022-03-30] | ||
| Filed 2021-09-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Applvn PS | [2022-03-30] | ||
| Filed 2021-03-11 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Ltest PS | [2022-03-30] | ||
| Filed 2021-01-21 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Owlet PS | [2022-03-30] | ||
| Filed 2021-02-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Transform III PS | [2022-03-30] | 40.0 M | |
| Filed 2022-01-06 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC AMTC PS | [2021-03-30] | 35.0 M | 0.5 M |
| Offered $35,000,000 · Filed 2020-06-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Lcovd PS | [2021-03-30] | ||
| Filed 2020-07-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC Lcovd Safe PS | [2021-03-30] | ||
| Filed 2020-11-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | EPQ LLC LFLU PS | [2021-03-30] | 17.5 M | |
| Offered $17,500,000 · Filed 2020-01-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 234 | 2.8 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 86 | 2.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 896 | 4.9 |
| By Discretionary | ||
| Discretionary | 647 | 2.7 |
| Non-Discretionary | 249 | 2.3 |
| Total | 896 | 4.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.1 | |
| United States Persons | 4.9 | |
| Total | 896 | 4.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Epiq Capital Group LLC | Director | 110 | 3 | |
| Epiq Capital Group LLC | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001779453] | |
| 3 | [0001779453] | |
| 4 | [0001779453] | |
| 5 | [0001779453] | |
| SC 13D | [0001779453] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| EPIQ Capital Group LLC | Lucira Health Inc | [2021-02-12] |
| EPIQ Capital Group LLC | Applied Molecular Transport Inc | [2020-06-18] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional, Retail |
| Fund Types | Private Equity |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 293,278 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 2,149,292 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 3,394,948 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2023-12-27 | Other | 2,500,000 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 3,461,764 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 735,475 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 725,675 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 3,754,084 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 5,173,026 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2022-12-14 | Other | 256,742 | ||
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2022-05-13 | Buy | 29,763 | $4.17 | 124,112 |
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2022-05-12 | Buy | 32,380 | $3.88 | 125,634 |
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2021-11-17 | Buy | 7,135 | $22.38 | 159,681 |
|
Applied Molecular Transport Inc AMTI
Common Stock
|
2021-11-16 | Buy | 4,000 | $22.57 | 90,280 |
|
Lucira Health Inc LHDX
Series B Convertible Preferred · derivative
|
2021-02-05 | Conversion | 32,176 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 735,475 | $17.00 | 12,503,075 |
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 3,754,084 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 32,176 | ||
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Buy | 3,461,764 | $17.00 | 58,849,988 |
|
Lucira Health Inc LHDX
Common Stock
|
2021-02-05 | Conversion | 5,173,026 | ||
| showing 20 of 45 most recent transactions | |||||